Solanezumab

2 treatments and conditions followed through the public trial records. Not medical advice. How a status is set

Treatments and conditions

Solanezumab
Treatment and conditionWhere it standsTrials
Solanezumab for alzheimer diseasePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)7
Solanezumab for cognitive dysfunctionTrial registered, as of 19 Nov 2026 (not yet checked by a person)1